Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 3 |
2023 | 2 |
2024 | 2 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis.
Blood. 2023 Sep 28;142(13):1143-1155. doi: 10.1182/blood.2022019274.
Blood. 2023.
PMID: 37294920
Synthesis and Structural Optimization of 2,7,9-Trisubstituted purin-8-ones as FLT3-ITD Inhibitors.
Tomanová M, Kozlanská K, Jorda R, Jedinák L, Havlíková T, Řezníčková E, Peřina M, Klener P, Dolníková A, Cankař P, Kryštof V.
Tomanová M, et al. Among authors: dolnikova a.
Int J Mol Sci. 2022 Dec 18;23(24):16169. doi: 10.3390/ijms232416169.
Int J Mol Sci. 2022.
PMID: 36555810
Free PMC article.
Item in Clipboard
Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas.
Jakša R, Karolová J, Svatoň M, Kazantsev D, Grajciarová M, Pokorná E, Tonar Z, Klánová M, Winkowska L, Maláriková D, Vočková P, Forsterová K, Renešová N, Dolníková A, Nožičková K, Dundr P, Froňková E, Trněný M, Klener P.
Jakša R, et al. Among authors: dolnikova a.
Lab Invest. 2022 Sep;102(9):957-965. doi: 10.1038/s41374-022-00784-w. Epub 2022 Apr 29.
Lab Invest. 2022.
PMID: 35488033
Free PMC article.
Item in Clipboard
Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion.
Malarikova D, Jorda R, Kupcova K, Senavova J, Dolnikova A, Pokorna E, Kazantsev D, Nozickova K, Sovilj D, Bellanger C, Chiron D, Andera L, Krystof V, Strnad M, Helman K, Klanova M, Trneny M, Havranek O, Klener P.
Malarikova D, et al. Among authors: dolnikova a.
Exp Hematol Oncol. 2024 Mar 25;13(1):34. doi: 10.1186/s40164-024-00499-2.
Exp Hematol Oncol. 2024.
PMID: 38528594
Free PMC article.
Item in Clipboard
MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients.
Horak J, Dolnikova A, Cumaogullari O, Cumova A, Navvabi N, Vodickova L, Levy M, Schneiderova M, Liska V, Andera L, Vodicka P, Opattova A.
Horak J, et al. Among authors: dolnikova a.
Front Oncol. 2022 Oct 17;12:959407. doi: 10.3389/fonc.2022.959407. eCollection 2022.
Front Oncol. 2022.
PMID: 36324569
Free PMC article.
Item in Clipboard
Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping.
Břehová P, Řezníčková E, Škach K, Jorda R, Dejmek M, Vojáčková V, Šála M, Kovalová M, Dračínský M, Dolníková A, Strmeň T, Kinnertová M, Chalupský K, Dvořáková A, Gucký T, Mertlíková Kaiserová H, Klener P, Nencka R, Kryštof V.
Břehová P, et al. Among authors: dolnikova a.
J Med Chem. 2023 Aug 24;66(16):11133-11157. doi: 10.1021/acs.jmedchem.3c00575. Epub 2023 Aug 3.
J Med Chem. 2023.
PMID: 37535845
Free PMC article.
Item in Clipboard
Blockage of BCL-XL overcomes venetoclax resistance across BCL2-positive lymphoid malignancies irrespective of BIM status.
Dolnikova A, Kazantsev D, Klanova M, Pokorna E, Sovilj D, Kelemen CD, Tuskova L, Hoferkova E, Mraz M, Helman K, Curik N, Machova Polakova K, Anděra L, Trněný M, Klener P.
Dolnikova A, et al.
Blood Adv. 2024 May 7:bloodadvances.2024012906. doi: 10.1182/bloodadvances.2024012906. Online ahead of print.
Blood Adv. 2024.
PMID: 38713893
Item in Clipboard
Cite
Cite